Page last updated: 2024-12-08

n-desmethylzopiclone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID162892
SCHEMBL ID11485705
MeSH IDM0150836

Synonyms (16)

Synonym
6-(5-chloro-2-pyridyl)-7-((1-piperazinyl)carbonyloxy)-6,7-dihydro(5h)pyrrolo(3,4-b)pyrazin-5-one
n-desmethyl-zopiclone
n-desmethylzopiclone
59878-63-6
FT-0666252
[6-(5-chloropyridin-2-yl)-5-oxo-7h-pyrrolo[3,4-b]pyrazin-7-yl] piperazine-1-carboxylate
1-piperazinecarboxylic acid, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5h-pyrrolo(3,4-b)pyrazin-5-yl ester
6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate
6-(5-chloropyrid-2-yl)-7-oxo-5-(piperazin-1-yl)carbonyloxy-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
SCHEMBL11485705
AKOS025395703
norzopiclone
CS-7301
HY-U00199
n-desmethyl zopiclone
DTXSID10866775

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"001), Cmax values of 87."( Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
Farinotti, R; Fernandez, C; Gimenez, F; Maradeix, V; Thuillier, A,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" The potentiation was related to a leftward shift in the GABA dose-response curves, suggesting the drug acts to increase GABA binding affinity."( Molecular actions of (S)-desmethylzopiclone (SEP-174559), an anxiolytic metabolite of zopiclone.
Fleck, MW, 2002
)
0.31
" No significant difference in concentrations was found between the two dosing groups for either zopiclone or N-desmethylzopiclone."( Distribution of zopiclone and main metabolites in hair following a single dose.
Hansen, SL; Johansen, SS; Kronstrand, R; Nielsen, MKK; Nilsson, G, 2020
)
0.77
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's5 (35.71)18.2507
2000's6 (42.86)29.6817
2010's1 (7.14)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.00 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (6.25%)4.05%
Observational0 (0.00%)0.25%
Other13 (81.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]